Is RSF stem cell therapy? No — it is acellular, DNA-free and RNA-free. What is actually in the vial, and why the two are so persistently confused.
No. Regenerative signaling factors are not a stem-cell therapy, and the two are not close enough for the words to be used interchangeably.
That is the entire answer to the question in the title. What takes longer is explaining why the question keeps arising, why a number of clinics (some of them sincerely) give a blurrier version of it, and why the difference is worth more than a footnote.
Ultra RSF (Regenerative Signaling Factors) is a concentrate of more than 300 proteins and growth factors, drawn from six regions of the placenta. During manufacture the material is purified until every living cell has been removed, and the result is free of DNA and RNA. Nothing in the vial is alive.
A stem-cell preparation is the opposite proposition in the ways that matter. It contains living cells carrying donor DNA, obtained through an invasive harvest, varying from donor to donor, and dependent on an unbroken cold chain to survive the journey. Every one of those properties comes from the presence of cells, and none of them applies to an acellular concentrate. The full comparison is laid out in stem cells vs. exosomes vs. RSF.
The muddle is not entirely anyone's fault. Three separate things push in the same direction.
There is a fourth reason worth naming, which is that the honest description is less exciting. A vial of signalling proteins that may influence how tissue organises itself does not carry the mythology that living cells do. It also happens to be what is being administered.
Removing the cells is not a tidying step. It changes what the preparation is, and the consequences run all the way through how it is made, moved and given.
An acellular concentrate can be characterised by next-generation sequencing and mass spectrometry, so one batch can be compared against another on paper — where a cultured cell population varies with how the culture behaved that week. It can be freeze-dried and stored without refrigeration, then reconstituted with 1 mL of sterile water at the bedside. Nothing in it engrafts, divides, or persists as tissue, because there is nothing in it that could. How Ultra RSF is made goes through each of those steps.
One difference between these categories is described in terms of how long signalling is intended to persist after administration. The manufacturer frames it as a spectrum.
Read that carefully, because the phrasing is doing real work. "Designed to" describes an intention built into how the preparation is formulated. It is not a measured clinical effect, it is not a claim about how long any benefit lasts, and it should not be presented as either. We repeat it here because it is part of how the product is characterised, with the hedge attached rather than removed.
When patients ask whether this is stem-cell therapy, they are often asking something else: whether it is legitimate, whether it is the thing they have read alarming stories about, whether they are being sold something. Those are good instincts and they deserve a straight answer rather than a reassuring one.
Here is what we can tell you, and it is deliberately confined to what is verifiable. The vial contains no cells, no DNA and no RNA. Donor material is screened under 21 CFR 1271.55. Composition is characterised by sequencing and mass spectrometry. It is administered by a physician, inside a plan, after an evaluation. We are not going to tell you what any agency does or does not permit, because that is not ours to characterise and the clinics that do it most confidently tend to be the ones getting it wrong.
The useful question is not what a preparation is called. It is what the paperwork says is in it.
No. Ultra RSF is acellular, containing no living cells and no DNA or RNA. It concentrates the proteins and growth factors that cells release rather than the cells themselves.
No. Purification removes all living cells during manufacture, and the resulting material is characterised by next-generation sequencing and mass spectrometry before it is freeze-dried.
Because the phrase is familiar and sells more easily, and because the two categories share a source tissue and a scientific lineage. Neither of those makes the description accurate.
Ultra RSF is described as designed to persist for weeks, against days for stem cells and exosomes and minutes to hours for peptides. That describes how the preparation is formulated rather than a measured clinical result.
No. It is adjunctive and complements guideline-based medical care. Stay on your prescribed treatment and discuss any change with the clinician who prescribed it.
This article is general health information, not medical advice, and does not create a physician–patient relationship. It describes mechanisms reported in the literature rather than guaranteed outcomes; individual response varies. Regen MDs provides you an alternative to your current care, and is complementary to your guideline-based medical care. Ultra RSF (Regenerative Signaling Factors) is not a stem-cell therapy. Talk to a licensed clinician before starting, stopping, or changing any treatment.
Three preparations, three different contents — and a market that blurs them on purpose. A composition-by-composition comparison, with no outcome claims attached.
The reason so much regenerative research points away from the cells themselves, and what a physician is actually giving when the vial says signaling factors.
A consumer-protection checklist for a field that has very little of it — including how we would answer all twelve ourselves.
Thirty minutes with one of our physicians — no cost, no obligation — to review your history and set out the options honestly.